Type
. Primary multidrug-resistant leprosy, United States. Emerging infectious diseases. 2013;19(1):179-81.
Type
. Bullous lesions in leprosy: a rare phenomenon. Indian journal of dermatology, venereology and leprology. 2013;79(1):107-9.
Type
. The epidemiological consequences of leprosy-tuberculosis co-infection. Mathematical biosciences. 2013;241(2):225-37.
Type
. Role of cultural factors in the biopsychosocial model of psychosomatic skin diseases: an Indian perspective. Clinics in dermatology. 2013;31(1):62-5.
Type
. IL12B SNPs and copy number variation in IL23R gene associated with susceptibility to leprosy. Journal of medical genetics. 2013;50(1):34-42.
Type
. Gene expression profile and immunological evaluation of unique hypothetical unknown proteins of Mycobacterium leprae by using quantitative real-time PCR. Clinical and vaccine immunology : CVI. 2013;20(2):181-90.
Type
. Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy. Vaccine. 2013;31(5):813-9.
Type
. The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases. Disease models & mechanisms [Internet]. 2013;6(1):19-24. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529335/?report=classic
Type
. Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature. The American journal of tropical medicine and hygiene. 2013;88(2):236-40.
Type
. Severe leprosy reactions due to Mycobacterium lepromatosis. The American journal of the medical sciences. 2013;345(1):65-9.